Clustering Cognitive Decline Trajectories in Mild Alzheimer’s Dementia: Insights from the EXPEDITION3 Trial

Longitudinal cognitive and functional measurements can effectively identify more homogeneous groups among individuals with mild dementia due to AD. These identified groups differ in both baseline and longitudinal progression characteristics, providing insights to the heterogeneity of AD progression. Notably, clusters with similar baseline scores (e.g., Cluster 1 and Cluster 3) displayed markedly different trajectories, highlighting the need to consider longitudinal patterns to inform personalized treatment strategies and to facilitate enrichment designs in future AD clinical trial designs.

Authors

Institutions

Publication Details

Journal
Alzheimer s & Dementia
Published
2025-12-01
DOI
https://doi.org/10.1002/alz70859_103336
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clustering Cognitive Decline Trajectories in Mild Alzheimer’s Dementia: Insights from the EXPEDITION3 Trial

Tianchen Qian, Jeremy Lin, Bhargav Teja Nallapu, Ali Ezzati et al.
Alzheimer s & Dementia
Dementia and Cognitive Impairment Research
article

Clustering Cognitive Decline Trajectories in Mild Alzheimer’s Dementia: Insights from the EXPEDITION3 Trial

Tianchen Qian, Jeremy Lin, Bhargav Teja Nallapu, Ali Ezzati, Richard B. Lipton
article en

Abstract

Longitudinal cognitive and functional measurements can effectively identify more homogeneous groups among individuals with mild dementia due to AD. These identified groups differ in both baseline and longitudinal progression characteristics, providing insights to the heterogeneity of AD progression. Notably, clusters with similar baseline scores (e.g., Cluster 1 and Cluster 3) displayed markedly different trajectories, highlighting the need to consider longitudinal patterns to inform personalized treatment strategies and to facilitate enrichment designs in future AD clinical trial designs.

Alzheimer s & DementiaVol. 21(S5)
Albert Einstein College of Medicine (US), University of California, Irvine (US), Delft University of Technology (NL)
Openalex Percentile: Top 33%
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.